AI Enhances Women’s Cancer Care in Victoria with New Technology

An innovative AI technology developed in British Columbia is set to enhance women’s cancer treatment in Victoria. Researchers, including Dr. Jessica McAlpine and Dr. Ali Bashashati from BC Cancer and the University of British Columbia (UBC), are focusing on improving the diagnosis and treatment of endometrial cancer, which ranks as the sixth most common cancer among women worldwide.

Endometrial cancer poses unique challenges in diagnosis due to the ambiguous appearance of its cells, leading to potential inconsistencies in medical assessments. This variability complicates decisions regarding treatment options, making it crucial for healthcare providers to have reliable tools at their disposal. The research team has made significant strides by categorizing this cancer into four distinct groups based on different clinical outcomes. Yet, one group remained notably diverse, prompting the introduction of the ProMisE AI test.

AI’s Role in Cancer Diagnosis and Treatment

According to Dr. McAlpine, the AI system can analyze tumor images to uncover details that human pathologists may overlook. She remarked, “We were able to look at these images of tumours and identify things that the pathologist couldn’t see and that the molecular tools couldn’t identify.” This capability allows doctors to identify patients who may appear to have good prognoses but are actually at higher risk of poor outcomes. As a result, clinicians can tailor treatment plans more effectively, potentially preventing cancer recurrences.

The AI technology not only offers enhanced diagnostic capabilities but also promises to reduce unnecessary treatments for some patients. “Because of the tools we now have, some patients can avoid the toxicity of chemotherapy and radiation altogether,” Dr. McAlpine explained. This development could allow healthcare providers to deliver more personalized care, ultimately improving patient outcomes.

The implementation of these AI tools in treatment centers, including those in Victoria, is anticipated within the next year, pending necessary funding and approvals. “We plan to pilot it in a couple of centres, and Victoria is potentially one of those,” Dr. McAlpine stated. The city boasts a strong team of researchers and oncologists, making it an ideal location for this initiative.

Community Impact and Research Legacy

The potential for Victoria to serve as a pilot site holds special significance for Dr. Brad Nelson, who recently assumed the role of Immunotherapy Research Chair at BC Cancer in Victoria. He has expressed concern over the historical lack of research focused on women’s cancers, a cause close to his heart. This dedication is underscored by the legacy of Joyce Deeley, who succumbed to ovarian cancer in 2001. Her husband, Trev Deeley, made a significant donation of $5 million to establish the Trev & Joyce Deeley Research Centre in her memory.

William Litchfield, associate vice president of the BC Cancer Foundation on Vancouver Island, emphasized the importance of ongoing research in this field, stating, “The innovative research underway at BC Cancer is incredibly important and holds the potential to save lives on the Island and across B.C.” This statement coincides with the timing of Gynecological Cancer Awareness Month in September, highlighting the need for increased focus on women’s health issues.

The application of AI in the context of endometrial cancer is just the beginning, as Dr. McAlpine noted. She expressed enthusiasm for exploring further applications of AI technology, stating, “There are so many other applications we’re also looking at.” The integration of AI tools in cancer care represents a significant leap toward a more precise and personalized approach to treatment, moving away from one-size-fits-all methodologies.

As the project progresses, the collaboration between researchers and medical professionals in Victoria could serve as a model for future advancements in cancer care, significantly impacting the lives of patients and families across the region.